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Statistical detection of a rare class of objects in a two-class clas-
sification problem can pose several challenges. Because the class of
interest is rare in the training data, there is relatively little informa-
tion in the known class response labels for model building. At the
same time the available explanatory variables are often moderately
high dimensional. In the four assays of our drug-discovery applica-
tion, compounds are active or not against a specific biological target,
such as lung cancer tumor cells, and active compounds are rare. Sev-
eral sets of chemical descriptor variables from computational chem-
istry are available to classify the active versus inactive class; each
can have up to thousands of variables characterizing molecular struc-
ture of the compounds. The statistical challenge is to make use of
the richness of the explanatory variables in the presence of scant re-
sponse information. Our algorithm divides the explanatory variables
into subsets adaptively and passes each subset to a base classifier.
The various base classifiers are then ensembled to produce one model
to rank new objects by their estimated probabilities of belonging to
the rare class of interest. The essence of the algorithm is to choose
the subsets such that variables in the same group work well together;
we call such groups phalanxes.
1. Introduction. Our goal is detection of rare chemical compounds that
are active against a given biological target, such as lung cancer cells or the
HIV virus. Statistical detection of rare events in a highly unbalanced two-
class situation occurs in a variety of other applications. Detection of credit
card fraud [Bolton and Hand (2002)], spam email [Hastie, Tibshirani and
Friedman (2009)], terrorism threats and finding relevant documents in a
Google search are all examples of this problem.
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In drug discovery, rare active compounds are sought in huge chemical
libraries. Our goal is to develop a quantitative structure activity relationship
(QSAR) model relating the probability of activity to variables characterizing
chemical structure for use in ranking a large number of candidate compounds
and produce a shortlist rich in active compounds.
For improved analysis of four such drug-discovery problems relating to
four assays, we propose a new classification methodology. The response vari-
able in each study is the 0/1 compound activity status against a specific bio-
logical target. For each problem five descriptor sets of explanatory variables
are available to build a classifier of activity. The variables in the descrip-
tor sets characterize the chemical/molecular structures of the compounds
in different ways. Some have thousands of variables. In contrast, the assay
data are relatively uninformative. While the training data have thousands of
compounds, very few are active: the fraction of actives varies from about 1%
to 8% for the four assays. Thus, this paper aims to exploit the riches of up
to thousands of explanatory variables in the descriptor sets in the presence
of limited response information caused by imbalance.
Recursive partitioning [Hawkins and Kass (1982)] and classification trees
[Breiman et al. (1984)] have been successful for modeling drug-discovery
data. Rusinko et al. (1999) were able to apply recursive partitioning to large
structure-activity data sets with thousands to millions of molecular descrip-
tors by making recursive partitioning scale well computationally.
Ensemble methods that combine several classifiers to produce one model
are widely viewed as even more competitive for drug-discovery data. The
method of random forests [RF, Breiman (2001)], an ensemble of classification
trees, has attracted particular attention. Svetnik et al. (2003), Chen, Liaw
and Breiman (2004) and Polishchuk et al. (2009), for example, all showed
RF is a relatively accurate method for classifying chemical compounds in
QSAR studies. Bruce et al. (2007) compared several machine learning tools
for mining drug discovery data, including support vector machines and en-
sembles based on classification trees: bagging [Breiman (1996a)], boosting
[Freund and Schapire (1996)] and RF. The authors demonstrated that en-
sembles provide better predictive performances than nonensemble methods.
Hughes-Oliver et al. (2012) carried out a comprehensive comparison of 12
classifiers, including RF, to rank the compounds in several highly unbal-
anced two-class assay data sets in QSAR studies. Repeatedly, RF emerged
as one of the best ranking procedures. As we shall see, even RF, which is
one of the most competitive existing methods, may only find a minority of
the active compounds. There is much room for improvement.
Ensemble methods such as bagging and RF create a number of models to
average by repeatedly perturbing the data. RF also randomly selects the set
of explanatory variables considered at each iteration as a constituent tree
is built. In principle, however, like bagging, it has all variables available for
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each tree in the ensemble. In contrast, the method we introduce ensembles
classifiers built with distinct subsets of variables. The algorithm identifies a
number of such subsets, where the variables in a subset work well together
in the same model. We call such subsets phalanxes.
This notion of phalanxes exploits the richness of the dimensionality of
the explanatory variables in the following way. Each phalanx is a relatively
low-dimensional subset of variables, so each variable has an opportunity to
play a role in its model fit. In this way, variables in different models can
contribute to the overall classification model, without competing with each
other in the sense that one variable deselects another. Our phalanx-forming
algorithm can also be thought of as a special type of clustering of variables,
where “similarity” between a pair of variables or a pair of groups is working
well together in the same model, and “dissimilarity” means working well
when separated in different models, which are ultimately ensembled.
Natural subsets of variables are sometimes suggested by subject matter
knowledge. For example, in a single nucleotide polymorphism (SNP) geno-
typing application, Podder et al. (2006) used pairs of variables suggested a
priori by the different chemical procedures employed in the genotyping plat-
form. In the group LASSO and its variants [Yuan and Lin (2006), Meier,
van de Geer and Bu¨hlmann (2008)], given groups are evaluated by their
ability to work together with other groups, but in a single model. Most re-
lated to the proposed method is ensembles over classifiers based on single
variables, pairs of variables, etc., as used in the thesis of Wang (2005), but
again groups were not formed in a data-adaptive way.
In principle, any given base classification method can be used to model
the class response variable as a function of the explanatory variables in a
phalanx and to guide the data-adaptive grouping into phalanxes. We use RF
here because of its documented competitive performance for drug-discovery
data. Thus, our ultimate classifier is an ensemble across random forests,
itself an ensemble method, where each random forest only uses the variables
in one phalanx.
The remainder of the article is organized as follows. Section 2 describes
the four assay data sets and the five descriptor sets, and Section 3 defines
the assessment metrics to assess classification performance in the context
of ranking for this application. Section 4 describes the algorithm for pha-
lanx formation, leading to the final ensemble, which we call an ensemble of
phalanxes classifier. Section 5 presents performance results and comparisons.
Comparisons are made with RF and regularized random forests [RRF, Deng
and Runger (2013)], and with methods specifically designed for imbalanced
drug-discovery data. For more than a few tens of explanatory variables, the
proposed method needs to form initial groups, and results are also provided
for an application-specific approach to grouping versus more general, data-
adaptive ways. Section 5 also explores the statistical diversity of ensembles
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Table 1
Four assays from the Molecular Libraries Screening Center Network
Compounds Proportion
Assay Biological target (active) active
AID 348 Gaucher’s disease 4946 (48) 0.0097
AID 362 Tissue-damaging leukocytes 4279 (60) 0.0140
AID 364 Cytotoxicity 3311 (50) 0.0151
AID 371 Lung tumor cells 3312 (278) 0.0839
of phalanxes and the implications for finding chemically diverse active com-
pounds in the application. Finally, Section 6 draws some conclusions.
2. Data sets and variables. We analyze 20 data sets from four different
assays in the Molecular Libraries Screening Center Network. The response
data can be downloaded from http://pubchem.ncbi.nlm.nih.gov/.
For each assay the response variable is y, where y = 0,1 denotes inac-
tivity and activity, respectively, of a compound against a specific biological
target. Table 1 summarizes the four assays. Further information about AID
348 may be obtained from https://pubchem.ncbi.nlm.nih.gov/assay/
assay.cgi?aid=348, and similarly for the other three assays.
These four assays were investigated by Hughes-Oliver et al. (2012), and
all are imbalanced with a sparse proportion of active compounds. For three
of the assays the proportion of actives is around 0.01; these three have only
48–60 active compounds each, posing difficulties for any statistical modeling
method. For example, a classification tree would soon run short of active-
class objects and tend to build a shallow tree, only using a few important
variables. If there are many important variables, some must be omitted in
the path to any one terminal node.
The assays cover a range of drug-discovery applications. AID 348 screens
for inhibitors of mutant forms of beta-glucocerebrosidase, implicated in
Gaucher’s disease. AID 362 is a whole-cell assay for another inhibitor of pep-
tide binding, associated with tissue-damaging chronic inflammation. Multi-
ple mechanisms of activity [Young and Hawkins (1998)] are possible even
with the specific biological targets of AID 348 and 362 and even more likely
for the other two assays, AID 364 and AID 371. They are whole-cell live/dead
assays. Multiple mechanisms of activity, from multiple chemical structures,
call for correspondingly broad statistical modeling strategies such as the
ensemble method proposed herein. In our approach, constituent statistical
models use distinct sets of explanatory variables.
The principle underlying QSAR modeling in drug discovery is that activ-
ity (toxicity/drug potency) of a chemical compound is related to its molec-
ular structure, which can be characterized by chemical descriptors. These
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Table 2
Five descriptor sets generated by PowerMV and the number of nonconstant variables for
each of the four assays
Variables for assay
Descriptor set
Potential
variables AID 348 AID 362 AID 364 AID 371
Atom pairs (AP) 546 367 360 380 382
Burden numbers (BN) 24 24 24 24 24
Carhart atom pairs (CAP) 4662 1795 1319 1585 1498
Fragment pairs (FP) 735 570 563 580 580
Pharmacophores (PH) 147 122 112 120 119
explanatory variables or covariates are numeric variables that describe the
structure or shape of molecules.
We consider five sets of descriptors for each of the four assays, to give a
total of 4×5 = 20 data sets. The descriptor sets are the following: atom pairs
(AP); Burden numbers (BN) [Burden (1989), Pearlman and Smith (1999)];
Carhart atom pairs (CAP) [Carhart, Smith and Venkataraghavan (1985)];
fragment pairs (FP); and pharmacophores fingerprints (PH). The Burden
numbers are continuous descriptors, and the other four are bit strings where
each bit is set to “1” when a certain feature is present and “0” when it is
not. See Liu, Feng and Young (2005) and Hughes-Oliver et al. (2012) for
further explanation of the molecular properties captured by the descriptor
sets.
Table 2 summarizes the five descriptor sets, as generated by PowerMV
[Liu, Feng and Young (2005)]. PowerMV computes a total of 546, 24, 4662,
735 and 147 descriptor variables for AP, BN, CAP, FP and PH, respectively.
For the molecules in any given assay (see Table 1), some of the descriptors
may be constant (e.g., a chemical feature is always absent). Such constant
variables are removed, giving the numbers of nonconstant variables in Ta-
ble 2.
The bit-string descriptors have hundreds to thousands of variables, with
CAP having the most (1319–1795). The continuous BN descriptors have
the lowest dimensionality, with 24 variables for all assays. They are also
rich, however, in the sense that continuous variables possess good resolution
compared to binary variables.
3. Performance measures. We describe assessment metrics specific to
evaluating ranking procedures when the goal is to detect the few instances of
the rare class hidden in a large set of objects, as in finding active compounds
in a large chemical library. These metrics are used instead of misclassification
error, a standard criterion for classification performance in general, but one
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that is inappropriate for highly unbalanced classes [Zhu, Su and Chipman
(2006)].
For a given classifier, ranking of the compounds in a test set is based on
their estimated probabilities of activity, pˆi. The compound with the largest
pˆi is ranked first, etc. The goal is to rank the actives in the test set at the
top of the list. The performance measures relate to where the actives are in
the ranked list.
Let N be the total number of compounds in a test set, and let M ≤N be
the number of actives among them. Suppose the ranked list is cut off at n
compounds; for example, resources only allow follow-up of n leads from the
list. Let 0≤H(n)≤M be the number of actives or “hits” in the shortlist of
size n. Performance is measured by graphing H(n) or by computing one or
more numerical functionals of it.
3.1. Hit curve. The hit curve is a plot of H(n) versus n or, equivalently,
a plot of H(n)/M (proportion of actives found) versus p(n) = n/N (pro-
portion of test compounds considered). The hit curve shows the ranking
performance at all possible shortlist cutoff-points, n. Classifier 1 with hit
curve H1(n) is uniformly superior to classifier 2 with hit curve H2(n) if
H1(n)≥H2(n) for 1≤ n≤N , with strict inequality for at least one value of
n.
For example, Figure 1 shows hit curves for three ensemble classifiers: RF
applied to all the available variables, RRF, and ensemble of phalanxes (EPX,
described in Section 4). The three classifiers are applied here to the AID 348
assay and the BN descriptors. The plots show n up to 300, because actives
are sought early in a ranked list. Note that EPX dominates the other two
ensembles: its hit curve is uniformly above the other two. There is no clear
winner between RRF and RF, because their hit curves cross.
In the results of Section 5 we compare numerous hit curves, and it is
convenient to have a numerical criterion to summarize a hit curve. Two
such criteria are outlined next.
3.2. Average precision. The average precision (AveP) gives a single num-
ber summary for a hit curve. Suppose we shortlist the top n≤N compounds
and H(n) of them are active. Then
h(n) =
H(n)
n
∈ [0,1]
is the hit rate or precision for the top n ranked compounds. Naturally, we
want h(n) to be as large as possible at every n. Let 1≤ t1 < t2 < · · ·< tM ≤N
be the positions of the M active compounds in the ranked list. AveP is
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Fig. 1. Hit curves from three classifiers, RF, RRF, and EPX, for the AID 348 assay and
BN descriptors. The numbers in the legend are values of AveP, defined below in Section 3.2.
defined as the average of the hit rates at the points on the hit curve where
actives are found:
AveP =
1
M
[h(t1) + h(t2) + · · ·+ h(tM )].
AveP reaches the maximum value 1 when all of the actives are ranked be-
fore all the inactives. When there are tied pˆi values, and hence ties in the
ranked list of compounds, the expected value of AveP is computed under
random ordering of the compounds within each group of ties [Wang (2005),
Chapter 3].
The AveP values for RF, RRF and EPX in Figure 1 are 0.103, 0.080
and 0.152, respectively. EPX is a clear winner by the AveP measure, which
makes sense as its hit curve dominates the other two. By the AveP criterion,
RF is preferable to RRF.
We use AveP not only to evaluate classifiers but also to choose the pha-
lanxes in our algorithm (Section 4).
3.3. Initial enhancement. Initial enhancement (IE), defined by Kearsley
et al. (1996), is the precision at one specific shortlist length, n, normalized
by the proportion of actives in the entire collection of compounds:
IE =
h(n)
M/N
.
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Because IE is just a rescaling of the precision at n, both measures would
lead to the same conclusions, but IE is often given in QSAR studies to
measure the improvement relative to the expectation under random ranking.
Naturally, IE values (much) larger than 1 are desired. A drawback of IE
is that it depends on the particular shortlist size, n. Moreover, IE does
not distinguish whether the actives are ranked at the beginning or end of
the shortlist. Therefore, while we report IE performance results, the AveP
criterion is used to choose phalanxes in Section 4.
Following Hughes-Oliver et al. (2012), we use n= 300 throughout to cal-
culate IE. The IE values for RF, RRF and EPX in Figure 1 are 7.15, 6.18
and 9.27, respectively. Again EPX is the winner, and RF is the runner-up.
3.4. Balanced 10-fold cross-validation (CV). The assay data summa-
rized in Table 1 are used for training classifiers and testing them. Because
actives are sparse, throughout we use balanced 10-fold cross-validation to as-
sess performance. Thus, we randomly divide the data into 10 approximately
equal sized groups, each containing approximately 1/10 of the actives. When
a group serves as a test set, and the remaining nine groups are the training
data for a classifier, a pˆi value is obtained for every compound in the test
set. After all 10 groups have served as a test set, pˆi values are available for
all compounds and can be ranked to give a hit curve, as in Figure 1, or to
compute AveP or IE.
4. Phalanx-formation algorithm.
4.1. Phalanxes of variables. We borrow the term phalanx from the mil-
itary formation used by Alexander The Great and his father Philip II of
Macedon to deploy infantry soldiers in the battlefield. For psychological mo-
tivation, phalanxes were organized as groups of friends and family members.
As a result, the strength of a phalanx would depend upon the individual
strengths of its soldiers and the emotional bonds between them. A pha-
lanx was an autonomous fighting unit but could be ensembled with other
phalanxes to form a formidable military machine.
The analogy with classification is that the proposed algorithm selects
a group of variables in a statistical phalanx such that they form a strong
classifier when put together in a single model. In other words, the variables in
a phalanx work better together in a model than when separated in different
models. At the same time, the algorithm pays attention to the performance
of the overall strength of the final ensemble of models.
4.2. Phalanx formation. Even if the optimal number of phalanxes is
known, dividing the variables into phalanxes is a combinatorial problem.
With the higher-dimensional descriptor variables in Table 2, exhaustive
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Fig. 2. Algorithm for phalanx formation. D variables are partitioned into d initial groups,
screened down to s groups, combined into c candidate phalanxes, and then screened down
to p phalanxes in the final ensemble (D ≥ d≥ s≥ c≥ p).
search is infeasible, and the algorithm performs a greedy (look one iteration
ahead) optimization instead. The amalgamation of variables into phalanxes
resembles hierarchical clustering, but variables are clustered, not observa-
tions.
As shown in Figure 2, there are four main steps in the algorithm to group
the original D variables into p final phalanxes:
1. Initial grouping. The original D variables are partitioned into d ≤D
initial groups.
2. Screening. The d initial groups are screened down to s≤ d groups.
3. Hierarchical merging into phalanxes. The s screened groups are amal-
gamated hierarchically into c≤ s candidate phalanxes.
4. Screening. The c candidate phalanxes are screened down to p≤ c final
phalanxes.
At termination, p base classifiers are trained, one for each phalanx of vari-
ables. They form an ensemble of models: the pˆi values from the p classifiers
are averaged to give one value of pˆi for each compound.
We use RF as the base classifier for the ensemble of phalanxes throughout,
including phalanx formation. There are two reasons. As already mentioned,
RF is known to be a competitive method for drug-discovery data, so it
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will provide strong base classifiers for our ensemble. Second, during phalanx
formation its out-of-bag (OOB) estimated class probabilities provide as good
an assessment of performance as cross-validation [Breiman (1996b, 2001),
Tibshirani (1996), Wolpert and Macready (1999)]. Thus, the computational
expense of multiple fits in cross-validation is avoided. To further reduce
computation, for phalanx formation the number of trees grown is reduced
from the default of 500 to 150.
All steps in phalanx formation are guided by a chosen assessment measure,
a. We use AveP for a, but the final ensembles are also evaluated using IE, and
the algorithm trivially generalizes to other criteria. (The algorithm assumes
a is to be maximized, but the changes for a smaller-the-better criterion are
straightforward.)
The four steps of the algorithm are now described in greater detail;
1. Initial grouping. This optional step has two motivations. First, the di-
mensionality of the AP, CAP, FP and PH descriptors in Table 2 makes the
later hierarchical-merging step too computationally expensive, even with
the greedy implementation. At each iteration the algorithm considers amal-
gamating all pairs of groups, and the computational complexity (see Sec-
tion 4.4) is still quadratic in the number of groups, too demanding for all
but the BN descriptors. Second, the four higher-dimensional sets have binary
variables, and a single binary variable can only give two possible pˆi values.
Consequently, the initial classifiers are all extremely weak. In contrast, an
initial group of k > 1 binary variables can generate up to 2k possible ranks.
Guidance is available to group the AP, CAP, FP or PH descriptors from
the variable names. For FP, for example, there are seven variables relating to
the presence of two aromatic rings: AR 01 AR,AR 02 AR, . . . ,AR 07 AR.
Here, AR 01 AR represents two phenyl (aromatic) rings separated by one
bond, etc. These seven variables form one of the initial groups, similarly
the other groups. We have empirically verified that grouping by the vari-
able names provides better final classification accuracy than forming initial
groups at random. A data-adaptive alternative for grouping is presented in
Section 5.3.
In this way, the D original variables are grouped into d≤D initial groups,
denoted by g1, g2, . . . , gd. For the BN descriptors, this step is omitted: the
initial groups are the individual variables, that is, d=D = 24.
2. Screening of initial groups. We screen out weak initial groups to reduce
computational burden and noise.
To survive this step, a group must be strong in the sense of a comparison
with the distribution of the assessment criterion, a, under random ranking.
To compute this reference distribution, we randomly permute the 0/1 values
of the response variable y relative to the descriptor values and obtain the
corresponding value of a. Repeating for many random permutations results
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in an empirical distribution of a (we use 1000 repeats throughout), from
which we take the α quantile, denoted by aα (we use α= 0.95 for all reported
results). The algorithm also makes use of a0.5, the median of the empirical
distribution.
An initial group is deemed to be strong if the base classifier using its vari-
ables is competitive with aα. There are actually three tests, and a group gi
survives the initial screening if it passes at least one of them. The three tests
consider the performance of gi by itself, or when its variables are combined
with those in any other group gj , or when it forms an ensemble with any
other group.
Thus, we need to define the following performance measures. Denote by
pˆi(gi) the estimated probabilities of activity from the base classifier using
only the variables in gi, and let ai = a(pˆi(gi)) be the assessment measure.
Similarly, denote by pˆi(gi ∪ gj) the estimated probabilities of activity when
the variables in gi and gj (i 6= j) are all available to the base classifier to fit
a single model, and let
aij = a(pˆi(gi ∪ gj))(4.1)
be the resulting performance measure. Finally, consider the performance of
an ensemble of two models based on gi and gj , respectively. Probability
averaging of their two sets of estimated probabilities gives (pˆi(gi)+ pˆi(gj))/2
for ranking. The resulting assessment measure is
aij = a((pˆi(gi) + pˆi(gj))/2).(4.2)
Based on these various uses of gi and the corresponding assessment mea-
sures, gi is deemed to be strong and survives the initial screening if it passes
at least one of the following tests:
• gi is strong alone:
ai ≥ aα.(4.3)
• gi improves the strength of another group gj when gi and gj are used
together in a single model:
a0.5 + aij − aj ≥ aα for at least one j 6= i.(4.4)
The rationale is that aij−aj is the improvement from adding the variables
in gi to those in gj in a single model, an improvement that has to be
competitive with aα − a0.5.
• gi improves the strength of another group gj when gi and gj are in an
ensemble of two models:
a0.5 + aij − aj ≥ aα for at least one j 6= i.(4.5)
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After removing weak initial groups, the list of surviving groups is relabeled
as {G1,G2, . . . ,Gs} for the next step.
3. Hierarchical merging into phalanxes. This step to merge G1,G2, . . . ,Gs
into phalanxes of variables is the heart of the algorithm. It resembles hierar-
chical clustering, but merges groups of variables, not groups of observations.
Each iteration merges the pair of groups Gi and Gj that minimizes
mij = aij/aij ,
where aij and aij are defined in (4.2) and (4.1). Values of the ratio less
than 1 indicate that Gi and Gj perform better in a single model than when
ensembled in separate models. After each merge, the number of groups, s,
is reduced by 1, and one of the new groups is the union of two of the old
groups. The algorithm continues until mij ≥ 1 for all i, j, suggesting that
merging reduces performance and the groups should be ensembled.
The following example illustrates. For simplicity, consider only s = 3
initial groups (actually individual variables) from the BN descriptors and
assay AID 348. The three groups are G1 = WBN GC L 1.00, G2 =
WBN EN H 0.50 and G3 =WBN LP H 1.00. The AveP values when pairs
of groups are used together in a single model are a12 = 0.052, a13 = 0.037
and a23 = 0.054. When pairs of groups are ensembled, the AveP values are
a12 = 0.069, a13 = 0.050 and a23 = 0.031. Thus, the corresponding mij ratios
are 1.31, 1.36 and 0.57. As the variables G2 and G3 give the smallest mij
and it is less than 1, we merge G2 and G3 into a new group and there are
now s = 2 groups. At the next step it turns out that m12 = 1.18 and the
two new groups should not be merged. Thus, the algorithm terminates with
two candidate groups or phalanxes, one of which contains two of the original
variables.
In general, the c final groups are candidate phalanxes, PX1,PX2, . . . ,PXc.
4. Screening out weak phalanxes. A candidate phalanx is kept in the en-
semble if it is individually strong as defined in (4.3) or it is strong in an
ensemble with another phalanx as defined in (4.5). There is no need to
check condition (4.4), as there was an exhaustive search for merging groups
in the previous step.
The p surviving phalanxes from this second stage of screening form the
army or ensemble, PX(1), . . . ,PX(p), for ranking.
4.3. Ensemble of phalanxes. We fit p RF classifiers, one for each of the p
phalanxes of variables, and obtain probabilities of activity from them. Here,
500 trees are grown for each random forest, the default. For any test point,
the p probabilities of activity from the ensemble of phalanxes (EPX) are
averaged to give the final probabilities for ranking.
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4.4. Computational complexity. We now show that the computational
complexity of phalanx formation is O(d2) fits of the underlying base classifier
in the worst case. Recall d is the number of initial groups, or the number of
variables if there is no grouping.
The screening phase first involves d fits, one for each group. Then, models
are fit for all the unions of all possible pairs of groups, that is, d(d− 1)/2
fits. Hence, screening involves a total of d(d + 1)/2 fits. In the worst case,
no groups are removed by screening.
For the first merger of the phalanx formation stage, no new fits are re-
quired: the performance measures for individual groups and pairs of groups
to evaluate (4.1) are already available from the screening stage. If the algo-
rithm continues, two groups are merged to create a new one. At the second
iteration, one fit needs to be made for the new group just formed as well as
another d− 2 fits using the union of variables from the new group and one
of the other d− 2 groups, that is, a total of d− 1 fits. Note that we do not
need to refit models for all possible pairs of groups. In the next iteration,
with one fewer group, there are d− 2 fits, etc. In the worst case, phalanx
formation continues until there is only one phalanx remaining, for a total of
(d− 1) + (d− 2) + · · ·+ 1= d(d− 1)/2 fits.
Thus, between screening and phalanx formation, there are at most d2
fits. The computational burden caused by the dimensionality of four of
the five descriptor sets is greatly reduced by forming initial groups with
d≪D. Moreover, the computations are embarrassingly parallel: The many
fits necessary at any iteration can be made independently of each other.
Thus, parallel computation is straightforward using the R packages foreach,
iterators, doSNOW and doMPI.
5. Results.
5.1. Comparison with random forests. We consider 20 data sets: there
are four assays and each has five possible descriptor sets. For each data set an
EPX classifier is constructed, as described in Section 4; this is repeated three
times using different random seeds. The results from EPX are compared with
RF and RRF, constructed using the defaults in their respective R packages,
randomForest [Liaw and Wiener (2002)] and RRF [Deng and Runger (2013)].
We give detailed results for AID 348. Summary results will also be given for
the other three assays (AID 362, AID 364 and AID 371).
The last five columns of Table 3 summarize the steps in the EPX algorithm
of Section 4 for AID 348. For example, the descriptor set AP has a total of
367 variables arranged into 75 initial groups, of which 22 survive screening
in the first EPX run. The 22 groups are ultimately merged into 4 candidate
phalanxes, of which 2 survive screening. Thus, the final EPX classifier is an
ensemble of 2 phalanxes. Two further runs of EPX with different random
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Table 3
Number of variables, initial groups, screened groups, candidate phalanxes and screened
phalanxes for the AID 348 assay and five descriptor sets. There are three runs of the
EPX algorithm
Number of
Descriptor
set
Groups Phalanxes
Run Variables Initial Screened Candidate Screened
AP 1 367 75 22 4 2
2 19 8 5
3 22 8 4
BN 1 24 24 24 8 8
2 24 9 9
3 24 4 4
CAP 1 1795 455 398 13 10
2 128 8 8
3 352 17 12
FP 1 570 101 24 6 4
2 22 5 4
3 22 5 5
PH 1 120 21 5 1 1
2 5 3 2
3 5 1 1
seeds result in armies of 5 and 4 phalanxes, respectively. (The impact of the
variation in the number of phalanxes is reported later in this section.)
Table 3 shows that many of the initial groups are screened out from the
four descriptor sets based on binary variables: AP, CAP, FP, and PH. For
example, 71–75% of AP’s initial groups are dropped. For the other binary
descriptor sets, 13–72%, 76–78% and 76% of the initial groups are screened
out. In contrast, all of the continuous BN variables are always used.
The AveP performance measures are reported in Table 4 for EPX, RF and
RRF. (The description of two further methods, SRF and WRF appearing
in Table 4, is taken up in Section 5.2.) All results are based on balanced 10-
fold cross-validation. Because of randomness in cross-validation, especially
with such small frequencies of active-class compounds, cross-validation is re-
peated 16 times for different random, balanced data splits (16 times because
we initially had 16 processors conveniently available for parallel processing).
Table 4 therefore reports mean AveP across the 16 cross-validations. For
the binary descriptor sets AP, CAP, FP and PH—where there are many
descriptor variables and screening is presumably important—RRF outper-
forms RF. But for BN, RF outperforms RRF. Mean AveP is always largest
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Table 4
AveP averaged over 16 replications of balanced 10-fold cross-validation for EPX, RF,
RRF, SRF and WRF applied to the AID 348 assay and five descriptor sets (DS). The
last four columns show the number of times EPX has larger AveP among the 16 repeats
of cross-validation relative to RF, RRF, SRF and WRF
Mean AveP EPX beats
DS Run EPX RF RRF SRF WRF RF RRF SRF WRF
AP 1 0.182 0.063 0.081 0.052 0.058 16/16 16/16 16/16 16/16
2 0.194 16/16 16/16 16/16 16/16
3 0.146 16/16 16/16 16/16 16/16
BN 1 0.143 0.090 0.078 0.075 0.075 16/16 16/16 16/16 16/16
2 0.153 16/16 16/16 16/16 16/16
3 0.132 16/16 16/16 16/16 16/16
CAP 1 0.201 0.068 0.090 0.095 0.088 16/16 16/16 16/16 16/16
2 0.184 16/16 16/16 16/16 16/16
3 0.155 16/16 16/16 15/16 16/16
FP 1 0.157 0.077 0.098 0.091 0.099 16/16 16/16 16/16 16/16
2 0.130 16/16 16/16 15/16 16/16
3 0.157 16/16 16/16 16/16 16/16
PH 1 0.108 0.070 0.080 0.082 0.060 16/16 16/16 15/16 16/16
2 0.108 16/16 16/16 15/16 16/16
3 0.108 16/16 16/16 15/16 16/16
for EPX, however. The advantage of EPX is greatest for CAP, the set with
the largest number of descriptors.
Columns 8 and 9 in Table 4 show that EPX consistently beats RF and
RRF in all 16 repeats of cross-validation across all descriptor sets.
Figure 3 shows box-plots for the 16 values of AveP over the 16 cross-
validations. The three box-plots for EPX correspond to the three runs—with
different random seeds—in our cross-validation experiment. Despite exhibit-
ing some run-to-run variability, EPX consistently outperforms RF and RRF.
We could stabilize the algorithm by using RF with a larger number of trees
at the phalanx-formation stage, but this would increase the computational
burden of the algorithm.
To visualize the performance gains of EPX, the hit curves in Figure 1
(for descriptor set BN) and Figure 4 (for the other descriptor sets) are
from the first balanced 10-fold cross-validation. In all cases the hit curve for
EPX starts rising very quickly and dominates the curves for the other two
methods. In other words, EPX is more successful here in detecting actives
early in a list of ranked compounds.
Although we have formed armies of phalanxes by optimizing AveP, Table 5
shows they also have good performance in terms of the metric IE. Mean IE
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Fig. 3. Box-plots of AveP for the AID 348 assay and five descriptor sets from 16 repli-
cations of balanced cross-validation for RF (light gray), RRF (gray) and 3 armies of pha-
lanxes (dark gray).
averaged over the 16 replications of balanced cross-validation is consistently
larger for EPX.
EPX also exhibits strong performance when similar studies are performed
for the other three assays, AID 362, AID 364 and AID 371. Summary perfor-
mance measures are given in Tables 6, 7 and 8, respectively. For these assays,
the performances of EPX and RF are comparable for the smallest set of bi-
nary descriptors, PH, but EPX dominates for CAP, the largest descriptor
set and the one that overall provides the best results.
5.2. Methods for imbalanced data. A key property of the data for all four
assays is that active compounds are rare (Table 1), suggesting that methods
specific to imbalanced data might provide a more relevant benchmark for
comparison than off-the-shelf RF.
Chawla et al. (2002) proposed the synthetic minority over-sampling tech-
nique (SMOTE) and applied it to an assay from the National Cancer In-
stitute’s yeast anti-cancer drug screen. The method artificially generates
new examples of the minority class objects using their nearest neighbors. In
addition, the majority class is under-sampled, leading to a balanced data
set. Whereas these authors combined SMOTE with a single classification
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(a) Atom pairs (AP) (b) Carhart atom pairs (CAP)
(c) Fragment pairs (FP) (d) Pharmacophores (PH)
Fig. 4. Hit curves from RF (dashed line), RRF (dotted line) and EPX (solid line) for
the AID 348 assay. Results are given for four descriptor sets: (a) AP; (b) CAP; (c) FP;
and (d) PH. The numbers in parentheses in the legends are the values of AveP.
tree (C4.5), we combine it with RF, widely recognized as more powerful for
drug-discovery data. The R function SMOTE in the package DMwR with de-
fault settings adjusts the AID 348 data, for instance, in the following way.
The original 48 active compounds are augmented with 48× 2 = 96 synthetic
samples. Furthermore, the inactive compounds are randomly under-sampled
to leave 96× 2 = 192 cases. Hence, the SMOTE data have a more balanced
144 active compounds and 192 inactive compounds. The results for SMOTE
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Table 5
IE for RF, RRF and EPX averaged over 16 balanced
10-fold cross-validations for the AID 348 assay and five
descriptor sets
Ensemble AP BN CAP FP PH
RF 5.19 6.62 7.16 7.07 5.53
RRF 5.80 6.25 6.83 7.28 5.78
EPX 6.27 8.80 8.20 8.40 6.44
with RF, called SRF in Tables 4 and 6–8, show that overall SRF performs
about the same as RF here, and sometimes worse. EPX still dominates.
The method of weighted random forests [WRF, Chen, Liaw and Breiman
(2004)] was partially motivated by QSAR applications with imbalanced
data. It assigns large and small weights to the minority and majority class
compounds, respectively. Because of a known bug with weighting in the R
package randomForest, we increased the weight of active compounds by
duplicating them. For example, to make the AID 348 assay data balanced,
the 48 active compounds were repeated 102 times to have approximately as
Table 6
AveP averaged over 16 replications of balanced 10-fold cross-validation for EPX, RF,
RRF, SRF and WRF applied to the AID 362 assay and five descriptor sets (DS). The
last four columns show the number of times EPX has better AveP than RF, RRF, SRF
and WRF over the 16 replications
Mean AveP EPX beats
DS Run EPX RF RRF SRF WRF RF RRF SRF WRF
AP 1 0.300 0.280 0.256 0.159 0.203 16/16 16/16 16/16 16/16
2 0.306 15/16 16/16 16/16 16/16
3 0.295 13/16 15/16 16/16 16/16
BN 1 0.261 0.242 0.238 0.129 0.274 16/16 16/16 16/16 02/16
2 0.299 16/16 16/16 16/16 15/16
3 0.285 16/16 16/16 16/16 14/16
CAP 1 0.363 0.267 0.171 0.178 0.197 16/16 16/16 16/16 16/16
2 0.355 16/16 16/16 16/16 16/16
3 0.368 16/16 16/16 16/16 16/16
FP 1 0.315 0.266 0.174 0.196 0.188 16/16 16/16 16/16 16/16
2 0.323 16/16 16/16 16/16 16/16
3 0.306 16/16 16/16 16/16 16/16
PH 1 0.227 0.216 0.168 0.167 0.142 14/16 16/16 16/16 16/16
2 0.212 07/16 16/16 16/16 16/16
3 0.218 09/16 16/16 16/16 16/16
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Table 7
AveP averaged over 16 replications of balanced 10-fold cross-validation for EPX, RF,
RRF, SRF and WRF applied to the AID 364 assay and five descriptor sets (DS). The
last four columns show the number of times EPX has better AveP than RF, RRF, SRF
and WRF over the 16 replications
Mean AveP EPX beats
DS Run EPX RF RRF SRF WRF RF RRF SRF WRF
AP 1 0.291 0.265 0.230 0.204 0.289 16/16 16/16 16/16 09/16
2 0.292 16/16 16/16 16/16 09/16
3 0.310 16/16 16/16 16/16 15/16
BN 1 0.371 0.327 0.300 0.174 0.274 16/16 16/16 16/16 16/16
2 0.365 16/16 16/16 16/16 16/16
3 0.373 16/16 16/16 16/16 16/16
CAP 1 0.379 0.334 0.252 0.244 0.269 16/16 16/16 16/16 16/16
2 0.390 16/16 16/16 16/16 16/16
3 0.390 16/16 16/16 16/16 16/16
FP 1 0.318 0.305 0.261 0.257 0.202 15/16 16/16 16/16 16/16
2 0.320 16/16 16/16 16/16 16/16
3 0.317 14/16 16/16 16/16 16/16
PH 1 0.278 0.275 0.219 0.185 0.081 11/16 16/16 16/16 16/16
2 0.276 09/16 16/16 16/16 16/16
3 0.282 14/16 16/16 16/16 16/16
many cases as the 4898 inactive compounds. The results for WRF in Ta-
bles 4 and 6–8 again show little practical improvement versus RF. For AID
362 and the BN descriptors, WRF performs better than RF and approaches
the mean AveP of one of the EPX models, but CAP is the descriptor set of
choice here, and WRF performs worse than RF for it.
5.3. Initial groups. For the drug-discovery application, the initial groups
presented to the phalanx formation algorithm consist of variables in a de-
scriptor set with related names (Section 4.2). In other applications with-
out logical groups of names, how should initial groups be formed? Here we
demonstrate a data-adaptive method that does not use name information.
The goal is to find a diverse set of phalanxes. For binary descriptors,
the Jaccard dissimilarity index is appropriate and defined between binary
variables xi and xj as
dJ(xi, xj) = 1−
xi ∩ xj
xi ∪ xj
.
Here xi ∩ xj is the number of observations where xi and xj both take the
value 1, and xi ∪ xj is the number of observations where xi or xj take the
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Table 8
AveP averaged over 16 replications of balanced 10-fold cross-validation for EPX, RF,
RRF, SRF and WRF applied to the AID 371 assay and five descriptor sets (DS). The
last four columns show the number of times EPX has better AveP than RF, RRF, SRF
and WRF over the 16 replications
Mean AveP EPX beats
DS Run EPX RF RRF SRF WRF RF RRF SRF WRF
AP 1 0.327 0.315 0.281 0.311 0.313 16/16 16/16 16/16 16/16
2 0.331 16/16 16/16 16/16 16/16
3 0.328 16/16 16/16 16/16 15/16
BN 1 0.342 0.335 0.333 0.289 0.322 16/16 16/16 16/16 16/16
2 0.354 16/16 16/16 16/16 16/16
3 0.338 13/16 13/16 16/16 16/16
CAP 1 0.390 0.347 0.310 0.342 0.356 16/16 16/16 16/16 16/16
2 0.384 16/16 16/16 16/16 16/16
3 0.378 16/16 16/16 16/16 16/16
FP 1 0.358 0.362 0.338 0.338 0.320 03/16 15/16 16/16 16/16
2 0.358 04/16 14/16 16/16 16/16
3 0.364 12/16 16/16 16/16 16/16
PH 1 0.277 0.277 0.282 0.267 0.244 09/16 05/16 12/16 16/16
2 0.284 15/16 10/16 14/16 16/16
3 0.279 09/16 06/16 13/16 16/16
value 1, and 0≤ dJ(xi, xj)≤ 1. We compute the Jaccard distances between
variables via the vegdist function in package vegan and hierarchically clus-
ter the variables (not observations) using hclust in R with method ward.
For consistency, the number of clusters equals the number of groups formed
from the names. For example, the AP descriptors of AID 348 again have 75
initial groups.
Table 9 compares average AveP for EPX with initial groups based on
the variables names versus initial groups from clustering. Results are given
for assays AID 348 and AID 371 and the four binary descriptor sets. These
two assays have the smallest and largest proportions of actives, respectively,
and cover a range of performances of EPX relative to RF. The results show
that neither method for generating initial groups is uniformly better. One
difference of note is that for AID 348, EPX with clusters makes some im-
provement with the CAP descriptors. As CAP and AP already perform well
for AID 348, CAP with clusters emerges as the method of choice. Overall,
the clustering method is a viable data-adaptive approach to forming initial
groups here.
5.4. Diversity. Breiman (2001) argued that the classification performance
of an ensemble method increases with the strengths of the underlying clas-
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Table 9
AveP from EPX averaged over 16 replications of balanced 10-fold cross-validation, with
initial groups formed from the variables’ names (Names) or clusters based on the Jaccard
index (Clusters)
Mean AveP of EPX
AID 348 AID 371
Descriptor
set Run Names Clusters Names Clusters
AP 1 0.182 0.200 0.327 0.339
2 0.194 0.163 0.331 0.334
3 0.146 0.121 0.328 0.336
CAP 1 0.201 0.258 0.390 0.386
2 0.184 0.275 0.384 0.388
3 0.155 0.167 0.378 0.380
FP 1 0.157 0.166 0.358 0.373
2 0.130 0.170 0.358 0.364
3 0.157 0.175 0.364 0.364
PH 1 0.108 0.087 0.277 0.284
2 0.108 0.102 0.284 0.276
3 0.108 0.113 0.279 0.273
sifiers being averaged and their diversity. We now illustrate that ensembles
from phalanxes can have these desirable traits.
Figure 5 depicts a diversity map [Hughes-Oliver et al. (2012)] of ranks
from cross-validated probabilities for AID 364 and the BN descriptors. The
ranks of the 50 active compounds are shown for the four underlying pha-
lanxes (denoted PX-1 through PX-4) and their EPX ensemble in the first
EPX run, and for random forests. This particular map relates to the first
cross-validation. The 50 active compounds on the right axis of the figure are
ordered according to the ranks from EPX. Ideally, they would have ranks
1–50, depicted by black to mid-gray on the gray scale on the left of the
figure. Lighter colors indicate a failure to rank well the active compounds.
It is seen in Figure 5 that PX-1 through PX-4 assign different ranks, that
is, they show a fair degree of diversity. This is beneficial, as averaging prob-
abilities providing the same ranks is unlikely to improve on the underlying
performances. If one phalanx misses an active compound (lighter gray on
the rank scale in Figure 5), we see that other phalanxes might rank it well
(darker gray on the rank scale).
Moreover, the AveP values for PX-1 through PX-4 reported on the x-axis
of Figure 5 range from 0.240 to 0.367. PX-2 by itself beats the 0.349 AveP
value from RF using all 24 BN descriptor variables. Thus, PX-1 through
PX-4 include one classifier that is strong relative to RF, and they constitute
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Fig. 5. Diversity map of ranks for the AID 364 assay and BN descriptors from the
first run of EPX and the first cross-validation. The AveP values of PX-1 through PX-4,
EPX and RF are given on the x-axis. The y-axis has the 50 active compounds, ordered by
their ranks from EPX. A darker gray on the gray scale indicates a smaller rank (higher
probability of activity).
a diverse set for an ensemble. Hence, the AveP of 0.374 for EPX is also
relatively high.
AID 364 is highlighted in this analysis, because it is a whole-cell live/dead
assay likely to have multiple mechanisms of activity from multiple chemical
structures. We now explore how diversity of the four phalanxes formed from
the BN descriptors translates into diversity of the active chemical structures
identified by them.
We focus attention on the structures differentiating EPX’s performance.
Sorting the active compounds by their absolute difference in ranks from
EPX versus RF leads to Table 10. The six largest discrepancies all favor
EPX: there are no actives ranked substantially higher by RF than by EPX.
The structures of these six compounds presented in Figure 6 have differ-
ences in some sub-structures, particularly across phalanxes, which may be
chemically significant. Identifying a variety of structures offers more leads
for the next stages of drug development, where compounds are adjusted to
increase efficacy, and compounds that are toxic and mutagenic in further
screens have to be removed.
The inactive compounds in the list of top 300 compounds identified by
EPX also show some diversity. Clustering the 270 inactive compounds in
the list, according to the 24 BN descriptors via hclust in R with method
ward, leads to two distinct clusters according to the CH index computed
by NbClust. Again, this is not surprising, as all the compounds in the top-
ranked list, including the inactives, result from several phalanx models.
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Table 10
Six active compounds where EPX and RF have the largest absolute difference in ranks
for the AID 364 assay and BN descriptors. The actives are identified by PubChem’s
compound identification (CID) number. Ranks are also given for the individual
phalanxes; the best rank among them is in bold
Rank from
CID PX-1 PX-2 PX-3 PX-4 EPX RF
657713 106 715 102 1082 133 943
661140 2099 353 649 52 158 847
657803 101 651 1833 744 241 1220
4993 94 1003 2673 932 245 2040
5389334 114 2737 1833 2376 364 2040
661535 537 211 1511 2376 738 1417
Further inspection of the compounds classified by EPX as active is reveal-
ing. Compounds CID 661658 and CID 660076 are ranked 3 and 12 by EPX
and have the similar structures shown in Figure 7. Compound CID 661658
is active, whereas CID 660076 is not. A small difference in structure like
this, that determines activity versus inactivity, may be helpful to a chemist
in designing an even more potent structure.
(a) CID 657803 (PX-1) (b) CID 4993 (PX-1) (c) CID 5389334 (PX-1)
(d) CID 661535 (PX-2) (e) CID 657713 (PX-1 and PX-3) (f) CID 661140 (PX-4)
Fig. 6. Six active compounds ranked substantially higher by EPX than RF for assay AID
364 and the BN descriptors. For each compound, the phalanx(es) giving a high rank are
indicated after the compound identification (CID).
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(a) CID 661658 (active) (b) CID 660076 (inactive)
Fig. 7. Compounds CID 661658 and CID 660076 are ranked 3 and 12, respectively, by
EPX for assay AID 364 and the BN descriptors. They have similar structures, but CID
661658 is active, while CID 660076 is not.
6. Conclusions and discussion. The concept of phalanxes of variables
was motivated by data sets with little information in the response variable
relative to the dimensionality of the explanatory variables. Scant information
in the response variable arises in drug discovery because molecules in the
biologically active class of interest are rare. Thus, it will be difficult to use
more than a few of the explanatory variables in a single model, even if
many of them are potentially useful. An ensemble of phalanxes uses distinct
explanatory variables in each of several models, hence, many variables have
a chance to contribute to classification performance. The phalanx-formation
algorithm is guided by this aim. The best ranking performance, both in
absolute terms and relative to RF and RRF, is seen for the CAP descriptor
set, which has the most variables. Adapting RF for imbalanced data did
not make it competitive with EPX here. Thus, we speculate that it is the
sparsity of information, caused by imbalance, and not imbalance itself, that
is the key factor in EPX’s performance.
Often one of the phalanxes by itself will give a classifier that outperforms
RF or RRF using all the variables. In this sense phalanx-formation provides
an effective variable selection or regularization for QSAR studies [Goodarzi,
Dejaegher and Vander Heyden (2012)]. But this is just a bonus. The EPX
algorithm attempts to identify several such competitive subsets of variables
in its various phalanxes. Averaging their models in an ensemble usually
provides the greatest advantage.
The proposed method is not a stand-alone classifier. It works on top of
a base method. For the drug discovery problem the base classifier was RF,
because that method was among the best known for such applications. The
phalanx method divides up the variables and gives each subset of them to
the RF method. It then combines the different results from the various RF
models (one model per subset of variables) into one model. In that sense,
the phalanx method sits on top of a base classifier like RF and improves it.
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Thus, the method is potentially extensible to other applications with a
richness of explanatory variables but other statistical aims such as regression
or survival analysis. The user needs to provide a competitive base statistical
method for the problem and a metric for the quality of a model. Phalanx-
formation to improve the base method would then be guided by the metric,
closely following the algorithm in Section 4.
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